Skip to main content
Premium Trial:

Request an Annual Quote

LifeMap to Offer ProSpec-Tany TechnoGene Products

NEW YORK (GenomeWeb News) – LifeMap Sciences today announced an exclusive distribution deal with ProSpec-Tany TechnoGene to offer more than 1,000 recombinant proteins and antibodies.

LifeMap, a subsidiary of BioTime, will offer the products at the start of 2013. Many of the proteins and antibodies covered by the deal are related to stem cell research, such as growth factors, signaling molecules, differentiation factors, hormones, cytokines, and chemokines, it said, adding that ProSpec's products complement the research product lines of BioTime offered through the LifeMap BioReagents portal.

ProSpec manufactures recombinant proteins and is based in Rehovet, Israel.

LifeMap is the principal marketing and sales arm of BioTime's cell-based products and related reagents for use in academia, research hospitals, and biotech and pharmaceutical firms.

LifeMap has an exclusive license to market the GeneCards and MalaCards databases, and it will soon add links to the ProSpec products in those databases as well as its own LifeMap Discovery database for biomedical and stem cell research, which is anticipated to launch later this year.

"This agreement represents a significant step for our LifeMap BioReagents portal, enabling us to place high quality recombinant proteins in the hands of our research community user base, and increasing our product portfolio and brand awareness," Yaron Guan-Golan, head of marketing for LifeMap Sciences, said in a statement.

Financial and other terms of the deal were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.